Search for Clinical Trial Results

Sponsored By

Cystadenocarcinoma, Mucinous - 2 Studies Found

Status Study
Active, not recruiting Study Name: Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
Condition:
  • Borderline Ovarian Mucinous Tumor
  • Ovarian Mucinous Cystadenocarcinoma<
    Date: 2010-03-04
    Interventions:
    • Biological: Bevacizumab Given

Terminated Study Name: Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
Condition:
  • Adenocarcinoma of the Pancreas
  • Adenocarcinoma of the Stomach
  • Drug: veliparib Given PO